Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter.
Lindeboom
J E
JE
Department of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands.
Kingma
J H
JH
Crijns
H J
HJ
Dunselman
P H
PH
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001282:Atrial Flutter / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010627:Phenethylamines / Q000008:administration & dosage / Q000627:therapeutic use*; D026902:Potassium Channel Blockers; D012449:Safety; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D010627:Phenethylamines; D026902:Potassium Channel Blockers; D013449:Sulfonamides; C063533:dofetilide